|
|
Article: ANDA approved for Taro's alcometetasone and gabapentin.(abbreviated new drug application of Taro Pharmaceutical Industries)(Brief Article)
- Article from:
- Pharma Marketletter
- Article date:
- September 26, 2005
CopyrightCOPYRIGHT 2005 Marketletter Publications Ltd. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
New York State, USA-based Taro Pharmaceutical Industries says it has received approval from the Food and Drug Administration for its Abbreviated New Drug Application for aclometasone dipropionate cream USP, 0.05%.
Taro says its product is bioequivalent to GlaxoSmithKline's Aclovate Cream, a topical corticosteroid prescription product used for the treatment of inflammatory skin conditions in adults and in pediatric patients one year of age or older. According to industry ...